Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
McKesson
Daiichi Sankyo
Deloitte
Cantor Fitzgerald
Healthtrust
Julphar
UBS

Generated: November 12, 2018

DrugPatentWatch Database Preview

Auranofin - Generic Drug Details

« Back to Dashboard

What are the generic sources for auranofin and what is the scope of auranofin patent protection?

Auranofin is the generic ingredient in one branded drug marketed by Sebela Ireland Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for auranofin. Two suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for auranofin
Synonyms for auranofin
(1-Thio-.beta.-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate
[1-(Thio-|ES)-|A-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold
34031-32-8
4-(2-aminoethyl)benzene sulfonyl fluoride hydrochloride
AC1OCFGC
AKOS026750078
B7687
CA003139
CA009493
CTK8F7877
D0L2UN
FT-0662343
Gold, (1-thio-.beta.-D-glucopyranosato)(triethylphosphine)-, 2,3,4,6-tetraacetate
GOLD(1+) ION [3,4,5-TRIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]OXAN-2-YL]SULFANIDE TRIETHYLPHOSPHINE
gold(1+); (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane
KS-00001FB9
MMV688978
Ridaura (TN)
Ridauran
SCHEMBL5188854
SK&F 39162
SK&F-39162

US Patents and Regulatory Information for auranofin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for auranofin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985 ➤ Sign Up ➤ Sign Up
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985 ➤ Sign Up ➤ Sign Up
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
McKesson
Daiichi Sankyo
Deloitte
Cantor Fitzgerald
Healthtrust
Julphar
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.